Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
20,561,240
-
Shares change
-
+6,460,791
-
Total reported value, excl. options
-
$416,160,000
-
Value change
-
+$130,784,664
-
Number of buys
-
23
-
Number of sells
-
-6
-
Price
-
$20.24
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2016
33 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q4 2016.
Ascendis Pharma A/S - ADR (ASND) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,561,240 shares
of 55,574,229 outstanding shares and own 37% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (5,409,990 shares), FMR LLC (3,152,532 shares), ORBIMED ADVISORS LLC (2,717,315 shares), Vivo Capital, LLC (1,766,832 shares), DEERFIELD MANAGEMENT CO (1,050,000 shares), BAKER BROS. ADVISORS LP (1,023,266 shares), EcoR1 Capital, LLC (975,700 shares), VHCP Management II, LLC (721,152 shares), JANUS CAPITAL MANAGEMENT LLC (594,295 shares), and ACUTA CAPITAL PARTNERS, LLC (575,309 shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.